Essential Medical has received CE mark approval for Manta, the company’s large bore vascular closure device.
Nicolas Van Mieghem, principal investigator in the EU study of the device, medical director of the Department of Interventional Cardiology at the Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands, comment, ” Our experience in the CE mark clearly showed Manta can change and improve access site management in the field of large-bore interventions. These challenging procedures will become safer and faster with Manta.”
Manta is a vascular closure device designed to close punctures ranging from 10F to 24F at femoral arterial access sites after cardiac catheterisation procedures such as transcatheter aortic valve replacement, endovascular treatment of abdominal aortic aneurysms, ventricular assist, and balloon aortic valvuloplas
ty.
Manta was designed to address the complexities of closing large punctures in high-pressure vessels utilising novel closure technology. According to a company release, Manta’s fail-safe deployment provides immediate haemostasis in order to reduce complications associated with large bore closure.
